Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Clinical trial NCT05429632 · RECRUITING

Trial details

NCT number: NCT05429632
Sponsor: Priothera SAS
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Acute Myeloid Leukemia

Start date: 2022-06-16
Primary completion: 2027-05-01
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.